Functional Mitral Regurgitation following Successful Living Donor Kidney Transplant: The VINTAGE Study
Cardiorenal Medicine · 31.03.2026 · 16 (1) · 288-300
DOI: 10.1159/000551778 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiorenal Medicine, online erschienen am 31.03.2026. Verfasst von Sumi Hidaka und 4 weiteren Autor:innen. Beteiligte Einrichtung: Kidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kanagawa, Japan, s_hidaka@shonankamakura.or.jp. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Kidney Transplantation, Living Donors. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Functional mitral regurgitation (FMR) is prevalent in CKD patients, but few studies have evaluated the effect of kidney transplant (KT) on FMR. This study aimed to clarify KT’s effect on FMR.
Methods
This study included 115 living-donor KT recipients (2012–2023). Primary outcome was change in FMR severity (5 categories: none to severe) based on echocardiographic findings before and 1 year post-KT. Aortic regurgitation (AR) severity and changes in left atrial diameter (LAD), left ventricular end-diastolic dimension (LVDd), ANP, and BNP levels were also assessed. Change in FMR and AR severity was assessed using Wilcoxon signed-rank tests. Multivariable logistic regression models were used to identify factors associated with the worsening of FMR and AR.
Results
At baseline, 76.5% had trivial FMR; 22.6% had mild/moderate/severe FMR. One year post-KT, moderate/severe FMR disappeared. Overall, FMR improved in 19.1%, remained unchanged in 73.1%, and worsened in 7.8%. FMR severity distribution significantly changed (p = 0.004). Reductions in LAD/LVDd aligned with decreased ANP/BNP. Multivariable analysis identified acute ABMR as an independent factor for worsening FMR (OR = 4.02, 95% CI: 1.81–8.91, p < 0.001). No significant AR improvement was observed (p = 0.377). A history of arrhythmia (OR = 2.68, 95% CI: 1.28–5.64, p = 0.009) and stroke (OR = 2.27, 95% CI: 1.12–4.59, p = 0.023) were identified as an independent factor for worsening AR.
Conclusion
KT is associated with an improvement in FMR among patients with kidney failure. This is likely due to LA/LV reverse remodeling from reduced volume/pressure overload. However, this benefit may diminish with graft dysfunction (e.g., acute rejection). Conversely, KT is not associated with an improvement in AR. Our findings highlight another important cardioprotective benefit of successful KT. Further prospective studies are needed to better understand this association.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Kidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kanagawa, Japan, s_hidaka@shonankamakura.or.jp.
- Kidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kanagawa, Japan.
- Kidney Transplant and Robotic Surgery Center, Shonan Kamakura General Hospital, Kanagawa, Japan.
Zitieren
APA
Hidaka, S., Yamano, M., Mochida, Y., Tanabe, K., & Kobayashi, S. (2026). Functional Mitral Regurgitation following Successful Living Donor Kidney Transplant: The VINTAGE Study. Cardiorenal Medicine, 16(1), 288-300. https://doi.org/10.1159/000551778
Vancouver
Hidaka S, Yamano M, Mochida Y, Tanabe K, Kobayashi S. Functional Mitral Regurgitation following Successful Living Donor Kidney Transplant: The VINTAGE Study. Cardiorenal Medicine. 2026;16(1):288-300. doi:10.1159/000551778
BibTeX
@article{Hidaka2026,
author = {Hidaka, Sumi and Yamano, Mizuki and Mochida, Yasuhiro and Tanabe, Kazunari and Kobayashi, Shuzo},
title = {Functional Mitral Regurgitation following Successful Living Donor Kidney Transplant: The VINTAGE Study},
journal = {Cardiorenal Medicine},
year = {2026},
volume = {16},
number = {1},
pages = {288--300},
doi = {10.1159/000551778}
}
EUVIMED